Jingfeng Zhou
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
-
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 3
- Co-authors
- Jingxuan Pan (13 shared papers)Bei Jin (4 shared papers)Yanli Jin (7 shared papers)Wei Dai (5 shared papers)Xin Du (3 shared papers)Yangqiu Li (5 shared papers)Yun Wang (2 shared papers)Yun Wang (4 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Molecular Cancer (2 papers)Science Translational Medicine (2 papers)Cancer Research (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jingfeng Zhou
20 papers receiving 620 citations
Peers
Comparison fields: 5 of 78
- Ophthalmology 75
- Hematology 98
- Molecular Biology 381
- Oncology 114
- Geriatrics and Gerontology 14
Countries citing papers authored by Jingfeng Zhou
This map shows the geographic impact of Jingfeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingfeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingfeng Zhou more than expected).
Fields of papers citing papers by Jingfeng Zhou
This network shows the impact of papers produced by Jingfeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingfeng Zhou. The network helps show where Jingfeng Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingfeng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 135 | |
| 2 | 2016 | 75 | |
| 3 | 2017 | 56 | |
| 4 | 2019 | 52 | |
| 5 | 2017 | 51 | |
| 6 | 2021 | 45 | |
| 7 | 2016 | 37 | |
| 8 | 2018 | 31 | |
| 9 | 2017 | 27 | |
| 10 | 2018 | 26 | |
| 11 | 2012 | 24 | |
| 12 | 2021 | 22 | |
| 13 | 2019 | 14 | |
| 14 | 2007 | 10 | |
| 15 | 2020 | 8 | |
| 16 | Study on Chemical Constituents of Cinnamomum Camphora Leaves | 2014 | 5 |
| 17 | 2025 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2019 | 1 |
About Jingfeng Zhou
Jingfeng Zhou is a scholar working on Molecular Biology, Hematology, Ophthalmology, Genetics and Oncology, having authored 23 papers that have together received 626 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Ocular Oncology and Treatments (6 papers), Ubiquitin and proteasome pathways (3 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Protein Degradation and Inhibitors (2 papers), Corneal Surgery and Treatments (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Ophthalmology (75 citations), Hematology (98 citations), Molecular Biology (381 citations), Oncology (114 citations) and Geriatrics and Gerontology (14 citations). Jingfeng Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jingxuan Pan, Bei Jin, Yanli Jin, Wei Dai, Xin Du, Yangqiu Li, Yun Wang, Yun Wang, Danian Nie and Juan Li. Their work appears in journals such as Clinical Cancer Research, Molecular Cancer, Science Translational Medicine, Cancer Research and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.